Statistics. Statistics = everything you need to know, but continually want to forget!!!!

Slides:



Advertisements
Similar presentations
DiseaseNo disease 60 people with disease 40 people without disease Total population = 100.
Advertisements

How to assess an abstract
Power and sample size.
Receiver Operating Characteristic (ROC) Curves
What Happens to the Performance of a Diagnostic Test when the Disease Prevalence and the Cut-Point Change? Pathological scores Healthy scores Healthy population.
TUTORIAL SCREENING Dr. Salwa Tayel, Dr. A. Almazam, Dr Afzal Mahmood
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
CRITICAL APPRAISAL Dr. Cristina Ana Stoian Resident Journal Club
Interpreting Basic Statistics
Epidemiology in Medicine Sandra Rodriguez Internal Medicine TTUHSC.
Introduction to Biomedical Statistics. Signal Detection Theory What do we actually “detect” when we say we’ve detected something?
Ghassan Fraij EBM Board Review 6/8/2009. Epidemiologic Measures ► Measures of disease occurrence:  Risk (the likelihood that and individual will contract.
Research Curriculum Session III – Estimating Sample Size and Power Jim Quinn MD MS Research Director, Division of Emergency Medicine Stanford University.
Statistical Fridays J C Horrow, MD, MSSTAT
Statistics By Z S Chaudry. Why do I need to know about statistics ? Tested in AKT To understand Journal articles and research papers.
Statistics for Health Care
Sample Size Determination
Sample Size and Statistical Power Epidemiology 655 Winter 1999 Jennifer Beebe.
Screening revision! By Ilona Blee. What are some UK Screening programmes?  Antenatal & newborn screening  Newborn Blood Spot  Newborn Hearing Screening.
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
Screening PHIL THIRKELL. What is screening?  A process of identifying apparently healthy people who may be at risk of a disease or condition  Identify.
(Medical) Diagnostic Testing. The situation Patient presents with symptoms, and is suspected of having some disease. Patient either has the disease or.
Sample size calculation
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
BASIC STATISTICS: AN OXYMORON? (With a little EPI thrown in…) URVASHI VAID MD, MS AUG 2012.
 Mean: true average  Median: middle number once ranked  Mode: most repetitive  Range : difference between largest and smallest.
Stats Tutorial. Is My Coin Fair? Assume it is no different from others (null hypothesis) When will you no longer accept this assumption?
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
Basic statistics 11/09/13.
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
Statistics for nMRCGP Jo Kirkcaldy. Curriculum Condensed Knowledge Incidence and prevalence Specificity and sensitivity Positive and negative predictive.
EDRN Approaches to Biomarker Validation DMCC Statisticians Fred Hutchinson Cancer Research Center Margaret Pepe Ziding Feng, Mark Thornquist, Yingye Zheng,
Prevention with Finasteride Ian M. Thompson, MD October, 2009.
Understanding real research 4. Randomised controlled trials.
Measures of Association Professor Mobeen Iqbal Shifa College of Medicine.
EBCP. Random vs Systemic error Random error: errors in measurement that lead to measured values being inconsistent when repeated measures are taken. Ie:
BIOE 301 Lecture Thirteen. Review of Lecture 12 The burden of cancer Contrasts between developed/developing world How does cancer develop? Cell transformation.
MEASURES OF TEST ACCURACY AND ASSOCIATIONS DR ODIFE, U.B SR, EDM DIVISION.
Likelihood 2005/5/22. Likelihood  probability I am likelihood I am probability.
Evidence-Based Medicine Diagnosis Component 2 / Unit 5 1 Health IT Workforce Curriculum Version 1.0 /Fall 2010.
Chris and Abbie’s Vital Statistics. It’s actually quite dull!!! But......It is quite easy if you think it through. Arghhh Statistics...
Stats Facts Mark Halloran. Diagnostic Stats Disease present Disease absent TOTALS Test positive aba+b Test negative cdc+d TOTALSa+cb+da+b+c+d.
Screening Puja Myles
Positive Predictive Value and Negative Predictive Value
Predictive values prevalence CK and acute myocardial infarction –sensitivity 70% –specificity 80% –prevalence - 40% –prevalence - 20% –PPV and NPV.
Organization of statistical research. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and.
Risks & Odds Professor Kate O’Donnell. When talking about the chance of something happening, e.g. death, hip fracture, we can talk about: risk and relative.
Compliance Original Study Design Randomised Surgical care Medical care.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
Diagnosis Examination(MMSE) in detecting dementia among elderly patients living in the community. Excel.
Hypothesis Testing Steps for the Rejection Region Method State H 1 and State H 0 State the Test Statistic and its sampling distribution (normal or t) Determine.
Timothy Wiemken, PhD MPH Assistant Professor Division of Infectious Diseases Diagnostic Tests.
PTP 560 Research Methods Week 12 Thomas Ruediger, PT.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Biostatistics: Pre-test Primer Larry Liang, MD University of Texas Southwestern Medical Center.
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
Risk Different ways of assessing it. Objectives Be able to define and calculate: Absolute risk (reduction) Relative risk (reduction) Number needed to.
What are the Chances Dr? Nick Pendleton. Can I have a Prostate Check? ?
CHAPTER 3 Key Principles of Statistical Inference.
2 3 انواع مطالعات توصيفي (Descriptive) تحليلي (Analytic) مداخله اي (Interventional) مشاهده اي ( Observational ) كارآزمايي باليني كارآزمايي اجتماعي كارآزمايي.
GP ST2 Group, 28/9/11 Tom Gamble
…it’s really interesting
Communicating Risk.
HelpDesk Answers Synthesizing the Evidence
NAPLEX preparation: Biostatistics
Figure 1. Table for calculating the accuracy of a diagnostic test.
Positive predictive value of screening tests
How to assess an abstract
Statistical Power.
Medical Statistics Exam Technique and Coaching, Part 2 Richard Kay Statistical Consultant RK Statistics Ltd 22/09/2019.
Presentation transcript:

Statistics

Statistics = everything you need to know, but continually want to forget!!!!

DISEASE PresentAbsent Positive TPFP Negative FNTN TEST

Sensitivity TP/TP + FN % of truly diseased patients who test positive PID = positive in disease

Specificity TN/TN + FP % of truly non-diseased patients who test negative NIH = negative in health

Positive Predictive Value TP/TP + FP % of patients having disease when test result is positive

Negative Predictive Value TN/TN +FN % of patients with negative test and no disease

PPV and NPV and prevalence PPV and NPV greatly influenced by the prevalence of the disease Increase the prevalence, increase the PPV, decrease the NPV More common a disease is in the population, the more likely it is that a positive test will be a true positive

How prevalence affects NPV & PPV Assume 80% sensitivity; 60% specificity PrevalencePPVNPV

Type I (alpha) error Trial concludes treatment is effective when there is no effect = false positive Standard 5% probability that difference seen in a trial due to chance alone Causes of type I error are chance and unmeasured difference in treatment groups

Type II (beta) error Trial concludes treatment ineffective when an effect exists = false negative Accepted level is 20% Causes of type II error are small sample size

Actual Treatment Effect RX worksRX doesn’t work Trial Result PositiveTrue positiveType I error NegativeType II errorTrue negative

Problem #1 400 patients studies for prostate CA 200 pts identified by biopsy as having ca All patients underwent PSA testing 160 pts correctly identified as having prostate CA 120 patients correctly identified as not having prostate CA

Calculate Sensitivity Specificity PPV NPV

Problem #2 Assume the prevalence of colon CA in SD county is 3% of all pts >50 yrs Hemmocult testing is 20% sensitive, 80% specific Calculate the predictive value of a positive test for detecting colon CA

Improved version of hemmocult testing is 50% sensitive and 90% specific Calculate the predictive value of a positive test for detecting colon cancer

Risk Relative Risk = The risk of an event after therapy as a percentage of risk without therapy RR= Exp event rate/control event rate Relative Risk Reduction=The proportional reduction in rates of bad events between exp and control groups RRR= 1-RR

Absolute Risk Reduction: The absolute arithmetic difference in rates between the exp and control groups ARR= Exp event rate – control event rate Number needed to treat: The # of patients who need to be treated to achieve one favorable outcome NNN= 1/ARR

Problem #3 If patients presenting with an evolving CVA are treated with ASA, their one month morbidity rate is 22% whereas the morbidity rate in ASA + plavix is 7%. Calculate: RR RRR ARR NNT